{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:26:09Z","timestamp":1760059569417,"version":"build-2065373602"},"reference-count":31,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"AstraZeneca","award":["ANR-10-LABX-0073"],"award-info":[{"award-number":["ANR-10-LABX-0073"]}]},{"name":"LABEX REVIVE","award":["ANR-10-LABX-0073"],"award-info":[{"award-number":["ANR-10-LABX-0073"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Cell therapy is promising for heart failure treatment, with growing interest in cardiovascular progenitor cells (CPCs) from pluripotent stem cells. A major challenge is managing the immune response, due to their allogeneic source. Regulatory T cells (Treg) offer an alternative to pharmacological immunosuppression by inducing immune tolerance. This study assesses whether Treg therapy can mitigate the xeno-immune response, improving cardiac outcomes in a mouse model of human CPC intramyocardial transplantation. CPCs stimulated immune responses in allogeneic and xenogeneic settings, causing proliferation in T cell subsets. Tregs showed immunosuppressive effects on T lymphocyte populations when co-cultured with CPCs. Post infarction, CPCs were transplanted intramyocardially into an immune-competent mouse model 3 weeks after myocardial infarction. Human or murine Tregs were intravenously administered on transplantation day and three days later. Control groups received CPCs without Tregs or saline (PBS). CPCs with Tregs improved LV systolic function in three weeks, linked to reduced myocardial fibrosis and enhanced angiogenesis. This was accompanied by decreased splenocyte NK cell populations and pro-inflammatory cytokine levels in cardiac tissue. Treg therapy with CPC transplantation enhances cardiac functional and structural outcomes in mice. Though it does not directly avert graft rejection, it primarily affects NKG2D+ cytotoxic cells, indicating systemic immune modulation and remote heart repair benefits.<\/jats:p>","DOI":"10.3390\/cells14130956","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T10:44:41Z","timestamp":1750761881000},"page":"956","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory T Cells Boost Efficacy of Post-Infarction Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cell Transplants"],"prefix":"10.3390","volume":"14","author":[{"given":"Aline Derisio","family":"de Lima","sequence":"first","affiliation":[{"name":"Integrative Physiopathology and Therapeutics of Cardiovascular Diseases, University of Paris Cit\u00e9, INSERM Unit 970, Paris Cardiovascular Research Center (PARCC), 56 Rue Leblanc, F-75015 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4344-9484","authenticated-orcid":false,"given":"Hern\u00e1n Gonzalez-King","family":"Garibotti","sequence":"additional","affiliation":[{"name":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43150 M\u00f6lndal, Sweden"},{"name":"Research and Early Development, Bioscience In Vivo, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43150 M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9570-4411","authenticated-orcid":false,"given":"Qing-Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43150 M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1133-8755","authenticated-orcid":false,"given":"Cecilia","family":"Graneli","sequence":"additional","affiliation":[{"name":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43150 M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5573-1914","authenticated-orcid":false,"given":"Tania","family":"Incitti","sequence":"additional","affiliation":[{"name":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43150 M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4178-0309","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Bellamy","sequence":"additional","affiliation":[{"name":"Integrative Physiopathology and Therapeutics of Cardiovascular Diseases, University of Paris Cit\u00e9, INSERM Unit 970, Paris Cardiovascular Research Center (PARCC), 56 Rue Leblanc, F-75015 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Eduarda Anast\u00e1cio Borges","family":"Corr\u00eaa","sequence":"additional","affiliation":[{"name":"Integrative Physiopathology and Therapeutics of Cardiovascular Diseases, University of Paris Cit\u00e9, INSERM Unit 970, Paris Cardiovascular Research Center (PARCC), 56 Rue Leblanc, F-75015 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6819-1322","authenticated-orcid":false,"given":"Myriam","family":"Assal","sequence":"additional","affiliation":[{"name":"Integrative Physiopathology and Therapeutics of Cardiovascular Diseases, University of Paris Cit\u00e9, INSERM Unit 970, Paris Cardiovascular Research Center (PARCC), 56 Rue Leblanc, F-75015 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8743-8846","authenticated-orcid":false,"given":"Makoto","family":"Miyara","sequence":"additional","affiliation":[{"name":"Immunology Department, INSERM Unit 1135, Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI), AP-HP, Sorbonne Universit\u00e9, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, 47-83 Bd de l\u2019H\u00f4pital, F-75013 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-2205","authenticated-orcid":false,"given":"Jean-S\u00e9bastien","family":"Silvestre","sequence":"additional","affiliation":[{"name":"Integrative Physiopathology and Therapeutics of Cardiovascular Diseases, University of Paris Cit\u00e9, INSERM Unit 970, Paris Cardiovascular Research Center (PARCC), 56 Rue Leblanc, F-75015 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1254-5158","authenticated-orcid":false,"given":"Karin","family":"Jennbacken","sequence":"additional","affiliation":[{"name":"Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43150 M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Menasch\u00e9","sequence":"additional","affiliation":[{"name":"Integrative Physiopathology and Therapeutics of Cardiovascular Diseases, University of Paris Cit\u00e9, INSERM Unit 970, Paris Cardiovascular Research Center (PARCC), 56 Rue Leblanc, F-75015 Paris, France"},{"name":"Department of Cardiovascular Surgery, H\u00f4pital Europ\u00e9en Georges Pompidou, 20 Rue Leblanc, F-75015 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"108185","DOI":"10.1016\/j.pharmthera.2022.108185","article-title":"Recent advances in the pharmacological therapy of chronic heart failure: Evidence and guidelines","volume":"238","author":"Tsutsui","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","article-title":"Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction","volume":"71","author":"Vanneaux","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"ltad007","DOI":"10.1093\/immadv\/ltad007","article-title":"Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: A perspective","volume":"3","author":"Sakaguchi","year":"2023","journal-title":"Immunother. Adv."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jgg.2022.05.005","article-title":"Current status and perspectives of regulatory T cell-based therapy","volume":"49","author":"Qu","year":"2022","journal-title":"J. Genet. Genom."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1172\/JCI90598","article-title":"Transplant trials with Tregs: Perils and promises","volume":"127","author":"Tang","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/acschembio.9b00075","article-title":"A Phenotypic Screening Approach Using Human Treg Cells Identified Regulators of Forkhead Box p3 Expression","volume":"14","author":"Ding","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41556-022-00899-8","article-title":"Migratory and anti-fibrotic programmes define the regenerative potential of human cardiac progenitors","volume":"24","author":"Poch","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.ymthe.2018.02.012","article-title":"Human ISL1+ Ventricular Progenitors Self-Assemble into an In Vivo Functional Heart Patch and Preserve Cardiac Function Post Infarction","volume":"26","author":"Foo","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/cvr\/cvaa028","article-title":"Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts","volume":"117","author":"Gomez","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2613.2007.00540.x","article-title":"Low coronary driving pressure early in the course of myocardial infarction is associated with subendocardial remodelling and left ventricular dysfunction","volume":"88","author":"Koike","year":"2007","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41591-021-01257-1","article-title":"Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys","volume":"27","author":"Tao","year":"2021","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.stemcr.2016.01.012","article-title":"Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates","volume":"6","author":"Kawamura","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e2022091118","DOI":"10.1073\/pnas.2022091118","article-title":"Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice","volume":"118","author":"Deuse","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.stem.2024.02.001","article-title":"Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate","volume":"31","author":"Hu","year":"2024","journal-title":"Cell Stem Cell"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Orozco, G., Gupta, M., Gedaly, R., and Marti, F. (2022). Untangling the Knots of Regulatory T Cell Therapy in Solid Organ Transplantation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.883855"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"EVIDoa2100009","DOI":"10.1056\/EVIDoa2100009","article-title":"Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease","volume":"1","author":"Zhao","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","article-title":"Co-transplantation of autologous Treg cells in a cell therapy for Parkinson\u2019s disease","volume":"619","author":"Park","year":"2023","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/cei\/uxae014","article-title":"Regulatory T cell frequency and function in acute myocardial infarction patients and its correlation with ventricular dysfunction","volume":"216","year":"2024","journal-title":"Clin. Exp. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s10741-022-10248-4","article-title":"The cardiosplenic axis: The prognostic role of the spleen in heart failure","volume":"27","author":"Hiraiwa","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.117.310599","article-title":"Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy","volume":"120","author":"Luger","year":"2017","journal-title":"Circ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.7150\/thno.46119","article-title":"Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction","volume":"1","author":"Sun","year":"2021","journal-title":"Theranostics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12265-022-10290-5","article-title":"The Role of Regulatory T Cells in Heart Repair After Myocardial Infarction","volume":"16","author":"Wang","year":"2023","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e004408","DOI":"10.1161\/JAHA.112.004408","article-title":"Deleterious effect of the IL-23\/IL-17A axis and \u03b3\u03b4T cells on left ventricular remodeling after myocardial infarction","volume":"1","author":"Yan","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1536\/ihj.52.382","article-title":"Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice","volume":"52","author":"Matsumoto","year":"2011","journal-title":"Int. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"H1233","DOI":"10.1152\/ajpheart.00328.2014","article-title":"Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function","volume":"307","author":"Saxena","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Omoto, A.C.M., Gava, F.N., Silva, C.A.A., Silva, H.B., Parente, J.M., Costa, R.M., Castro, M.M., Tostes, R.C., Salgado, H.C., and Fazan, R.J.r. (2018). Lack of scarring is not always a sign of cardiac health: Functional and molecular characterization of the rat heart\u2019s following chronic reperfusion. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0209190"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/ajt.15700","article-title":"Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation","volume":"20","author":"Whitehouse","year":"2020","journal-title":"Am. J. Transpl."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000303050","article-title":"Defective circulating CD4CD25+Foxp3+CD127(low) regulatory T-cells in patients with chronic heart failure","volume":"25","author":"Tang","year":"2010","journal-title":"Cell Physiol. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.cca.2010.08.013","article-title":"The Th17\/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction","volume":"411","author":"Li","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1802-2","article-title":"An acute immune response underlies the benefit of cardiac stem cell therapy","volume":"577","author":"Vagnozzi","year":"2020","journal-title":"Nature"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/13\/956\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:56:51Z","timestamp":1760032611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/13\/956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":31,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["cells14130956"],"URL":"https:\/\/doi.org\/10.3390\/cells14130956","relation":{},"ISSN":["2073-4409"],"issn-type":[{"type":"electronic","value":"2073-4409"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}